In addition, 1522 (60.0%) patients presented with Eastern Cooperative Oncology Group (ECOG) performance status ≥1, 1402 (55.2%) had less than three metastatic sites, 1308 (51.5%) had high PD‐L1 expression, and 1196 (47.1%) patients had stage IV cancer. The gene discussed is CD274; the disease is cancer.